This year, LuMind RDS is excited to be a Main Sponsor of the 2017 Trisomy 21 Research Society (T21RS) Conference from June 8 through 11 at the Feinberg School of Medicine of Northwestern University in the heart of the city of Chicago. Speakers represent Basic, Translational and Clinical Researchers and Funders from public and private sources. This is the Down syndrome meeting that brings all of the research components together. LuMind RDS will be represented by current Board officers, Hampus Hillestrom and Bjoern Sperling.
A highlight of the conference is the group’s commitment to working with the Ds community through their “Science & Society” committee. This committee works together with local Down syndrome associations to explain recent scientific findings they publish. Diana Bianchi (USA), director of NICHD, will chair a sub-session on ‘the pros and cons of having a relative with Down syndrome participate in clinical research’ where Margie Doyle, Board Emeritus, is sharing her experience supporting Down syndrome research, followed by a sub-session on ‘medical policies for people with Down syndrome’ chaired by Juan Fortea (Spain) and Cindy Lemere (USA).
T21RS is the first non-profit scientific organization of professional researchers and clinicians studying Down syndrome, founded to promote basic, translational and clinical research in Down syndrome and to apply new scientific knowledge to develop improved treatments and cures. One of the goals of the society is to to establish common protocols for (pre)clinical research, thereby harmonizing and standardizing the worldwide efforts to investigate Down syndrome, thus enabling better comparisons between studies across the globe. It is clear from their stated goals that this society takes very measured steps to ensure that the scientific community, from private enterprises to public policy leaders, are focused on Down syndrome research.
The society also stimulates emerging student interest in Down syndrome research with their efforts to:
- organize schools for young scientists interested in Down syndrome
- establish a network of host laboratories working on Down syndrome, where visiting young scientists may expand knowledge in different methodological and conceptual issues regarding Down syndrome
- provide grants to students to enable them to attend scientific conferences regarding Down syndrome
- issue thesis prizes in order to stimulate research on Down syndrome
Supporting public/private collaborative efforts such as T21RS is one way that LuMind RDS partners with like-minded organizations to stimulate biomedical research that will accelerate the development of treatments to significantly improve cognition, including memory, learning and speech, for individuals with Down syndrome.